Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Plasma-derived Factor VIII market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Plasma-derived Factor VIIImarket, defines the market attractiveness level of Plasma-derived Factor VIII market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Plasma-derived Factor VIII industry, describes the types of Plasma-derived Factor VIII market, the applications of major players and the market size, and deeply analyzes the current situation of the global Plasma-derived Factor VIII market and the development prospects and opportunities of Plasma-derived Factor VIII industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Plasma-derived Factor VIII market in Chapter 13.
By Player:
Kedrion
Hualan Bio
Octapharma
Greencross
BPL
Shire (Baxter)
Grifols
CSL
RAAS
By Type:
200IU
250IU
By End-User:
Hospital
Pharmacy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Plasma-derived Factor VIII Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Plasma-derived Factor VIII Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Plasma-derived Factor VIII Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Plasma-derived Factor VIII Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Plasma-derived Factor VIII Market Analysis and Outlook to 2022
-
7.1 Global Plasma-derived Factor VIII Consumption (2017-2022)
-
7.2 United States Plasma-derived Factor VIII Consumption (2017-2022)
-
7.3 Europe Plasma-derived Factor VIII Consumption (2017-2022)
-
7.4 China Plasma-derived Factor VIII Consumption (2017-2022)
-
7.5 Japan Plasma-derived Factor VIII Consumption (2017-2022)
-
7.6 India Plasma-derived Factor VIII Consumption (2017-2022)
-
7.7 South Korea Plasma-derived Factor VIII Consumption (2017-2022)
8 Region and Country-wise Plasma-derived Factor VIII Market Analysis and Outlook to 2028
-
8.1 Global Plasma-derived Factor VIII Consumption Forecast (2022-2028)
-
8.2 United States Plasma-derived Factor VIII Consumption Forecast (2022-2028)
-
8.3 Europe Plasma-derived Factor VIII Consumption Forecast (2022-2028)
-
8.4 China Plasma-derived Factor VIII Consumption Forecast (2022-2028)
-
8.5 Japan Plasma-derived Factor VIII Consumption Forecast (2022-2028)
-
8.6 India Plasma-derived Factor VIII Consumption Forecast (2022-2028)
-
8.7 South Korea Plasma-derived Factor VIII Consumption Forecast (2022-2028)
9 Global Plasma-derived Factor VIII Market Outlook by Types and Applications to 2022
-
9.1 Global Plasma-derived Factor VIII Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 200IU Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 250IU Consumption and Growth Rate (2017-2022)
-
9.2 Global Plasma-derived Factor VIII Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmacy Consumption and Growth Rate (2017-2022)
10 Global Plasma-derived Factor VIII Market Outlook by Types and Applications to 2028
-
10.1 Global Plasma-derived Factor VIII Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 200IU Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 250IU Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Plasma-derived Factor VIII Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
11 Global Plasma-derived Factor VIII Import and Export Analysis (Top 5 Countries)
-
11.1 Global Plasma-derived Factor VIII Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Plasma-derived Factor VIII Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Plasma-derived Factor VIII Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Plasma-derived Factor VIII Market Competitive Analysis
-
14.1 Kedrion
-
14.1.1 Kedrion Company Details
-
14.1.2 Kedrion Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Kedrion Plasma-derived Factor VIII Product and Service
-
14.2 Hualan Bio
-
14.2.1 Hualan Bio Company Details
-
14.2.2 Hualan Bio Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Hualan Bio Plasma-derived Factor VIII Product and Service
-
14.3 Octapharma
-
14.3.1 Octapharma Company Details
-
14.3.2 Octapharma Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Octapharma Plasma-derived Factor VIII Product and Service
-
14.4 Greencross
-
14.4.1 Greencross Company Details
-
14.4.2 Greencross Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Greencross Plasma-derived Factor VIII Product and Service
-
14.5 BPL
-
14.5.1 BPL Company Details
-
14.5.2 BPL Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 BPL Plasma-derived Factor VIII Product and Service
-
14.6 Shire (Baxter)
-
14.6.1 Shire (Baxter) Company Details
-
14.6.2 Shire (Baxter) Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Shire (Baxter) Plasma-derived Factor VIII Product and Service
-
14.7 Grifols
-
14.7.1 Grifols Company Details
-
14.7.2 Grifols Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Grifols Plasma-derived Factor VIII Product and Service
-
14.8 CSL
-
14.8.1 CSL Company Details
-
14.8.2 CSL Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 CSL Plasma-derived Factor VIII Product and Service
-
14.9 RAAS
-
14.9.1 RAAS Company Details
-
14.9.2 RAAS Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 RAAS Plasma-derived Factor VIII Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Plasma-derived Factor VIII
-
Figure Plasma-derived Factor VIII Picture
-
Table Global Plasma-derived Factor VIII Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Plasma-derived Factor VIII Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Plasma-derived Factor VIII Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Plasma-derived Factor VIII Consumption by Country (2017-2022)
-
Figure United States Plasma-derived Factor VIII Consumption and Growth Rate (2017-2022)
-
Table Europe Plasma-derived Factor VIII Consumption and Growth Rate (2017-2022)
-
Figure China Plasma-derived Factor VIII Consumption and Growth Rate (2017-2022)
-
Figure Japan Plasma-derived Factor VIII Consumption and Growth Rate (2017-2022)
-
Figure India Plasma-derived Factor VIII Consumption and Growth Rate (2017-2022)
-
Figure South Korea Plasma-derived Factor VIII Consumption and Growth Rate (2017-2022)
-
Figure Global Plasma-derived Factor VIII Consumption Forecast by Country (2022-2028)
-
Figure United States Plasma-derived Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Plasma-derived Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Plasma-derived Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Plasma-derived Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Plasma-derived Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Plasma-derived Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 200IU Consumption and Growth Rate (2017-2022)
-
Figure Global 250IU Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global 200IU Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 250IU Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Plasma-derived Factor VIII Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Plasma-derived Factor VIII Export by Region (Top 5 Countries) (2017-2028)
-
Table Kedrion (Foundation Year, Company Profile and etc.)
-
Table Kedrion Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kedrion Plasma-derived Factor VIII Product and Service
-
Table Hualan Bio (Foundation Year, Company Profile and etc.)
-
Table Hualan Bio Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hualan Bio Plasma-derived Factor VIII Product and Service
-
Table Octapharma (Foundation Year, Company Profile and etc.)
-
Table Octapharma Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma Plasma-derived Factor VIII Product and Service
-
Table Greencross (Foundation Year, Company Profile and etc.)
-
Table Greencross Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
Table Greencross Plasma-derived Factor VIII Product and Service
-
Table BPL (Foundation Year, Company Profile and etc.)
-
Table BPL Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
Table BPL Plasma-derived Factor VIII Product and Service
-
Table Shire (Baxter) (Foundation Year, Company Profile and etc.)
-
Table Shire (Baxter) Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire (Baxter) Plasma-derived Factor VIII Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Plasma-derived Factor VIII Product and Service
-
Table CSL (Foundation Year, Company Profile and etc.)
-
Table CSL Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Plasma-derived Factor VIII Product and Service
-
Table RAAS (Foundation Year, Company Profile and etc.)
-
Table RAAS Plasma-derived Factor VIII Sales, Price, Value and Gross Profit (2017-2022)
-
Table RAAS Plasma-derived Factor VIII Product and Service
-
